BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28128734)

  • 1. MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified.
    Lin Y; Chen WM; Wang C; Chen XY
    Cancer Biomark; 2017; 18(4):339-347. PubMed ID: 28128734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
    Li M; Lü N; Liu HX; Chen DB; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Piccaluga PP; Fuligni F; Rossi M; Agostinelli C; Righi S; Sapienza MR; Motta G; Gazzola A; Mannu C; Sabattini E; Bacci F; Tabanelli V; Sacchetti CA; Barrese TZ; Etebari M; Melle F; Clò A; Gibellini D; Tripodo C; Inghirami G; Croce CM; Pileri SA
    Blood Cancer J; 2014 Nov; 4(11):259. PubMed ID: 25382608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
    Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
    Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.
    Valleron W; Ysebaert L; Berquet L; Fataccioli V; Quelen C; Martin A; Parrens M; Lamant L; de Leval L; Gisselbrecht C; Gaulard P; Brousset P
    Blood; 2012 Nov; 120(19):3997-4005. PubMed ID: 22990019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
    Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T-cell lymphoma gene expression profiles.
    Martinez-Delgado B
    Hematol Oncol; 2006 Sep; 24(3):113-9. PubMed ID: 16676369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
    Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
    J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
    Agostinelli C; Piccaluga PP; Went P; Rossi M; Gazzola A; Righi S; Sista T; Campidelli C; Zinzani PL; Falini B; Pileri SA
    J Clin Pathol; 2008 Nov; 61(11):1160-7. PubMed ID: 18755717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.
    Lone W; Alkhiniji A; Manikkam Umakanthan J; Iqbal J
    Curr Hematol Malig Rep; 2018 Aug; 13(4):318-328. PubMed ID: 29951889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis in PTCL-NOS with CADM1 expression.
    Kato T; Miyoshi H; Kobayashi S; Yoshida N; Imaizumi Y; Seto M; Uchimaru K; Miyazaki Y; Ohshima K
    Virchows Arch; 2017 Nov; 471(5):659-666. PubMed ID: 28940014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
    Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
    Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.